According to the World Health Organization 25% of drugs are derived from plant molecules. 80% of the population in developing countries may be relying on plant derived drugs today.
Additionally, the number of new drugs developed per $1 billion of R&D spending has fallen from 10 in 1970 to under 1 today.
Plant-based APIs have a proven track record and a bright future.
Our technology allows us to provide a reliable source of novel and existing plant-based molecules to several industries: